Factorial Partners, LLC Biogen Inc. Transaction History

Factorial Partners, LLC

$146 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$256.56 - $292.34 $115,452 - $131,553	450 Added 8.33%	5,850 $1.63 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $416,526 - $506,088	-1,650 Reduced 23.4%	5,400 $1.5 Million
Q3 2022 Nov 04, 2022	SELL	$194.69 - $268.46 $350,442 - $483,227	-1,800 Reduced 20.34%	7,050 $1.88 Million
Q2 2022 Aug 03, 2022	BUY	$187.54 - $223.02 $225,048 - $267,624	1,200 Added 15.69%	8,850 $1.81 Million
Q1 2022 May 03, 2022	BUY	$193.77 - $244.14 $474,736 - $598,143	2,450 Added 47.12%	7,650 $1.61 Million
Q4 2021 Feb 09, 2022	BUY	$223.92 - $287.77 $167,940 - $215,827	750 Added 16.85%	5,200 $1.25 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $721,624 - $941,077	2,550 Added 134.21%	4,450 $1.26 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $1.89 Million - $3.03 Million	-7,300 Reduced 79.35%	1,900 $658,000
Q1 2021 May 21, 2021	SELL	$242.95 - $284.63 $623 Million - $730 Million	-2,564,500 Reduced 99.64%	9,200 $2.57 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $623 Million - $730 Million	2,563,000 Added 23953.27%	2,573,700 $9.2 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $200,821 - $302,285	-850 Reduced 7.36%	10,700 $2.62 Billion
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $232,794 - $308,295	900 Added 8.45%	11,550 $3.09 Billion
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $241,965 - $306,936	-900 Reduced 7.79%	10,650 $3.37 Billion
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $682,186 - $942,617	-3,100 Reduced 21.16%	11,550 $3.43 Billion
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $304,416 - $341,432	1,400 Added 10.57%	14,650 $3.41 Billion
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $1.1 Million - $1.21 Million	5,000 Added 60.61%	13,250 $3.1 Billion
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $1.79 Million - $2.8 Million	8,250 New	8,250 $1.95 Billion

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Factorial Partners, LLC with notifications on news.

Account